Fig. 4From: Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanningOverall survival calculated from primary diagnosis for patients with skull base meningiomas treated with particle therapy, regardless of histologyBack to article page